Published in Infect Immun on December 01, 2000
Current knowledge of type-specific M antigens of group A streptococci. J Immunol (1962) 14.71
Streptococcal M protein: alpha-helical coiled-coil structure and arrangement on the cell surface. Proc Natl Acad Sci U S A (1981) 5.56
QUANTITATIVE ANTISTREPTOKINASE STUDIES IN PATIENTS INFECTED WITH GROUP A HEMOLYTIC STREPTOCOCCI: A COMPARISON WITH SERUM ANTISTREPTOLYSIN AND GAMMA GLOBULIN LEVELS WITH SPECIAL REFERENCE TO THE OCCURRENCE OF RHEUMATIC FEVER. J Clin Invest (1948) 5.25
An immunological relationship between the group. A streptococcus and mammalian muscle. J Exp Med (1966) 4.89
IMMUNOLOGIC RELATION OF STREPTOCOCCAL AND TISSUE ANTIGENS. I. PROPERTIES OF AN ANTIGEN IN CERTAIN STRAINS OF GROUP A STREPTOCOCCI EXHIBITING AN IMMUNOLOGIC CROSS-REACTION WITH HUMAN HEART TISSUE. J Immunol (1963) 4.05
Group A streptococcal antigens cross-reactive with myocardium. Purification of heart-reactive antibody and isolation and characterization of the streptococcal antigen. J Exp Med (1977) 3.80
Streptococcal M6 protein expressed in Escherichia coli. Localization, purification, and comparison with streptococcal-derived M protein. J Exp Med (1984) 3.69
Protective antigenic determinant of streptococcal M protein shared with sarcolemmal membrane protein of human heart. J Exp Med (1982) 2.84
Tropomyosin-like seven residue periodicity in three immunologically distinct streptococal M proteins and its implications for the antiphagocytic property of the molecule. J Exp Med (1980) 2.75
Heart-reactive antibody associated with rheumatic fever: characterization and diagnostic significance. Clin Exp Immunol (1970) 2.62
Studies on group A streptococcal M-proteins: purification of type 5 M-protein and comparison of its amino terminal sequence with two immunologically unrelated M-protein molecules. J Immunol (1980) 2.62
Antigenic variation among group A streptococcal M proteins. Nucleotide sequence of the serotype 5 M protein gene and its relationship with genes encoding types 6 and 24 M proteins. J Biol Chem (1988) 2.61
Multiple, heart-cross-reactive epitopes of streptococcal M proteins. J Exp Med (1985) 2.61
Epitopes of streptococcal M proteins shared with cardiac myosin. J Exp Med (1985) 2.53
Influence of intranasal immunization with synthetic peptides corresponding to conserved epitopes of M protein on mucosal colonization by group A streptococci. Infect Immun (1988) 2.24
Immunochemical localization and amino acid sequences of crossreactive epitopes within the group A streptococcal M6 protein. J Exp Med (1986) 2.03
Homologous regions within M protein genes in group A streptococci of different serotypes. Infect Immun (1986) 1.85
Frequency and specificity of antiheart antibodies in patients with dilated cardiomyopathy detected using SDS-PAGE and western blotting. J Am Coll Cardiol (1993) 1.77
Mediation of cytotoxic effects of streptococcal M protein by nontype-specific antibody in human sera. J Clin Invest (1973) 1.74
Protection against streptococcal pharyngeal colonization with a vaccinia: M protein recombinant. Science (1989) 1.54
Sequence of myosin-crossreactive epitopes of streptococcal M protein. J Exp Med (1986) 1.43
Cross-reaction of group A streptococci and heart tissue: varying serologic specificity of cross-reactive antisera and relation to carrier-hapten specificity. Transplant Proc (1969) 1.39
Epitopes of group A streptococcal M protein that evoke cross-protective local immune responses. J Immunol (1992) 1.38
Human heart-infiltrating T-cell clones from rheumatic heart disease patients recognize both streptococcal and cardiac proteins. Circulation (1995) 1.36
The concept of autoantibodies in rheumatic fever and in the postcommissurotomy state. Ann N Y Acad Sci (1960) 1.36
Human and murine antibodies cross-reactive with streptococcal M protein and myosin recognize the sequence GLN-LYS-SER-LYS-GLN in M protein. J Immunol (1989) 1.27
Sequence of protective epitopes of streptococcal M proteins shared with cardiac sarcolemmal membranes. J Immunol (1987) 1.26
Tropomyosin shares immunologic epitopes with group A streptococcal M proteins. J Immunol (1989) 1.26
Streptococcal M protein peptide with similarity to myosin induces CD4+ T cell-dependent myocarditis in MRL/++ mice and induces partial tolerance against coxsakieviral myocarditis. J Immunol (1996) 1.17
Presence of a non-HLA B cell antigen in rheumatic fever patients and their families as defined by a monoclonal antibody. J Clin Invest (1989) 1.15
Identification of T cell autoepitopes that cross-react with the C-terminal segment of the M protein of group A streptococci. Int Immunol (1994) 1.13
Molecular analysis of human cardiac myosin-cross-reactive B- and T-cell epitopes of the group A streptococcal M5 protein. Infect Immun (1997) 1.11
Expression of protective and cardiac tissue cross-reactive epitopes of type 5 streptococcal M protein in Escherichia coli. Infect Immun (1985) 1.07
Towards a vaccine for rheumatic fever: identification of a conserved target epitope on M protein of group A streptococci. Lancet (1994) 1.04
Protective and autoimmune epitopes of streptococcal M proteins. Vaccine (1988) 0.98
Immunological relationship between the class I epitope of streptococcal M protein and myosin. Infect Immun (1998) 0.96
Serologic evidence for a class I group A streptococcal infection among rheumatic fever patients. J Infect Dis (1995) 0.95
Identification of an epitope of type 1 streptococcal M protein that is shared with a 43-kDa protein of human myocardium and renal glomeruli. J Immunol (1990) 0.93
Protective and heart-crossreactive epitopes located within the NH2 terminus of type 19 streptococcal M protein. J Exp Med (1988) 0.93
Autoimmune determinants of rheumatic carditis: localization of epitopes in human cardiac myosin. Eur Heart J (1991) 0.93
Surface-exposed conserved region of the streptococcal M protein induces antibodies cross-reactive with denatured forms of myosin. J Immunol (1993) 0.90
Rheumatic fever, rheumatic heart disease, and the streptococcal connection: the role of streptococcal antigens cross-reactive with heart tissue. Rev Infect Dis (1980) 0.88
Type-specific antibodies to structurally defined fragments of streptococcal M proteins in patients with acute rheumatic fever. Infect Immun (1982) 0.86
Radioimmunoassay of human cardiac tropomyosin in acute myocardial infarction. Clin Sci (Lond) (1981) 0.84
Relation of streptococcal M protein with human and rabbit tropomyosin: the complete amino acid sequence of human cardiac alpha tropomyosin, a highly conserved contractile protein. Biochem Biophys Res Commun (1987) 0.80
Antibodies in the sera of acute rheumatic fever patients bind to human cardiac tropomyosin. J Autoimmun (1997) 0.80
Persistent elevation of immunoglobulin G titer against the C region of recombinant group A streptococcal M protein in patients with rheumatic fever. Pediatr Res (1996) 0.78
Protective and heart-cross-reactive epitopes of type 19 streptococcal M protein. Trans Assoc Am Physicians (1987) 0.78
Regulation of exoprotein expression in Staphylococcus aureus by a locus (sar) distinct from agr. Proc Natl Acad Sci U S A (1992) 6.95
Sorting of protein A to the staphylococcal cell wall. Cell (1992) 6.48
Complete nucleotide sequence of type 6 M protein of the group A Streptococcus. Repetitive structure and membrane anchor. J Biol Chem (1986) 6.38
Streptococcal M protein: alpha-helical coiled-coil structure and arrangement on the cell surface. Proc Natl Acad Sci U S A (1981) 5.56
A major surface protein on group A streptococci is a glyceraldehyde-3-phosphate-dehydrogenase with multiple binding activity. J Exp Med (1992) 4.60
A method to isolate RNA from gram-positive bacteria and mycobacteria. Anal Biochem (1994) 4.24
Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H. Proc Natl Acad Sci U S A (1988) 3.82
Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase. Science (2001) 3.72
Streptococcal M6 protein expressed in Escherichia coli. Localization, purification, and comparison with streptococcal-derived M protein. J Exp Med (1984) 3.69
Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant. Proc Natl Acad Sci U S A (1997) 3.49
Size variation of the M protein in group A streptococci. J Exp Med (1985) 3.45
alpha-enolase, a novel strong plasmin(ogen) binding protein on the surface of pathogenic streptococci. J Biol Chem (1998) 3.37
Size variation in group A streptococcal M protein is generated by homologous recombination between intragenic repeats. Mol Gen Genet (1987) 3.32
Location of variable and conserved epitopes among the multiple serotypes of streptococcal M protein. J Exp Med (1985) 3.23
Variation in the expression of cell wall proteins of Staphylococcus aureus grown on solid and liquid media. Infect Immun (1988) 3.21
Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme. Proc Natl Acad Sci U S A (2001) 3.10
Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy. J Infect Dis (2000) 2.90
Conversion of an M- group A streptococcus to M+ by transfer of a plasmid containing an M6 gene. J Exp Med (1986) 2.89
Streptococcal M protein extracted by nonionic detergent. I. Properties of the antiphagocytic and type-specific molecules. J Exp Med (1976) 2.77
Tropomyosin-like seven residue periodicity in three immunologically distinct streptococal M proteins and its implications for the antiphagocytic property of the molecule. J Exp Med (1980) 2.75
Purification and physical properties of group C streptococcal phage-associated lysin. J Exp Med (1971) 2.67
Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region. Am J Trop Med Hyg (2001) 2.67
Studies on group A streptococcal M-proteins: purification of type 5 M-protein and comparison of its amino terminal sequence with two immunologically unrelated M-protein molecules. J Immunol (1980) 2.62
Expression of streptococcal M protein in Escherichia coli. Science (1983) 2.57
The importance of the location of antibody binding on the M6 protein for opsonization and phagocytosis of group A M6 streptococci. J Exp Med (1988) 2.42
The complete amino acid sequence of a biologically active 197-residue fragment of M protein isolated from type 5 group A streptococci. J Biol Chem (1984) 2.40
Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo. Virology (2001) 2.38
Isolation and characterization of the cell-associated region of group A streptococcal M6 protein. J Bacteriol (1988) 2.35
Myosin: a link between streptococci and heart. Science (1985) 2.28
Relationship of M protein genes in group A streptococci. Proc Natl Acad Sci U S A (1985) 2.24
Influence of intranasal immunization with synthetic peptides corresponding to conserved epitopes of M protein on mucosal colonization by group A streptococci. Infect Immun (1988) 2.24
Recovery of infectious human parainfluenza virus type 3 from cDNA. Virology (1997) 2.17
Evidence for two distinct classes of streptococcal M protein and their relationship to rheumatic fever. J Exp Med (1989) 2.15
Streptococcal M protein extracted by nonionic detergent. II. Analysis of the antibody response to the multiple antigenic determinants of the M-protein molecule. J Exp Med (1977) 2.13
Immunochemical localization and amino acid sequences of crossreactive epitopes within the group A streptococcal M6 protein. J Exp Med (1986) 2.03
Role of alpha-dystroglycan as a Schwann cell receptor for Mycobacterium leprae. Science (1998) 2.02
Recombinant respiratory syncytial virus that does not express the NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzees. J Virol (2000) 1.97
Characterization and biological properties of a new staphylococcal exotoxin. J Exp Med (1994) 1.91
DNA sequence of the serum opacity factor of group A streptococci: identification of a fibronectin-binding repeat domain. Infect Immun (1995) 1.91
The multistep proteolytic maturation pathway utilized by vaccinia virus P4a protein: a degenerate conserved cleavage motif within core proteins. Virology (1991) 1.86
Homologous regions within M protein genes in group A streptococci of different serotypes. Infect Immun (1986) 1.85
A live attenuated recombinant dengue-4 virus vaccine candidate with restricted capacity for dissemination in mosquitoes and lack of transmission from vaccinees to mosquitoes. Am J Trop Med Hyg (2001) 1.85
Mucosal and systemic immune responses to a recombinant protein expressed on the surface of the oral commensal bacterium Streptococcus gordonii after oral colonization. Proc Natl Acad Sci U S A (1995) 1.80
Requirements for the opsonic activity of human IgG directed to type 6 group A streptococci: net basic charge and intact Fc region. J Immunol (1983) 1.79
Sequence and structural characteristics of the trypsin-resistant T6 surface protein of group A streptococci. J Bacteriol (1990) 1.78
Identification of an endogenous membrane anchor-cleaving enzyme for group A streptococcal M protein. Its implication for the attachment of surface proteins in gram-positive bacteria. J Exp Med (1989) 1.77
Glyceraldehyde-3-phosphate dehydrogenase on the surface of group A streptococci is also an ADP-ribosylating enzyme. Proc Natl Acad Sci U S A (1993) 1.76
Peptic digestion of streptococcal M protein. I. Effect of digestion at suboptimal pH upon the biological and immunochemical properties of purified M protein extracts. Infect Immun (1974) 1.74
Fibrinogen acts as a bridging molecule in the adherence of Staphylococcus aureus to cultured human endothelial cells. J Clin Invest (1991) 1.73
Vacuum-assisted closure versus saline-moistened gauze in the healing of postoperative diabetic foot wounds. Ostomy Wound Manage (2000) 1.71
Presence of two distinct regions in the coiled-coil structure of the streptococcal Pep M5 protein: relationship to mammalian coiled-coil proteins and implications to its biological properties. Proc Natl Acad Sci U S A (1985) 1.68
The role of fibrinogen in staphylococcal adherence to catheters in vitro. J Infect Dis (1990) 1.64
Immunochemical analysis of intact M protein secreted from cell wall-less streptococci. Infect Immun (1981) 1.62
Spontaneous M6 protein size mutants of group A streptococci display variation in antigenic and opsonogenic epitopes. Proc Natl Acad Sci U S A (1988) 1.62
Nucleotide sequence analysis of the respiratory syncytial virus subgroup A cold-passaged (cp) temperature sensitive (ts) cpts-248/404 live attenuated virus vaccine candidate. Virology (1996) 1.60
Cell wall anchoring of the Streptococcus pyogenes M6 protein in various lactic acid bacteria. J Bacteriol (1997) 1.55
A human IgG receptor of group A streptococci is associated with tissue site of infection and streptococcal class. J Infect Dis (1990) 1.53
Nucleotide sequences of two adjacent M or M-like protein genes of group A streptococci: different RNA transcript levels and identification of a unique immunoglobulin A-binding protein. Infect Immun (1992) 1.53
Differentiation between two biologically distinct classes of group A streptococci by limited substitutions of amino acids within the shared region of M protein-like molecules. J Exp Med (1990) 1.52
Synergistic lethal effect of a combination of phage lytic enzymes with different activities on penicillin-sensitive and -resistant Streptococcus pneumoniae strains. Antimicrob Agents Chemother (2003) 1.51
Cloning, expression, and nucleotide sequence of a Staphylococcus aureus gene (fbpA) encoding a fibrinogen-binding protein. Infect Immun (1995) 1.50
Synthetic peptide vaccine against mucosal colonization by group A streptococci. I. Protection against a heterologous M serotype with shared C repeat region epitopes. J Immunol (1990) 1.50
Cytotoxic and viral neutralizing antibodies crossreact with streptococcal M protein, enteroviruses, and human cardiac myosin. Proc Natl Acad Sci U S A (1992) 1.49
Induction of lysogenic bacteriophage and phage-associated toxin from group a streptococci during coculture with human pharyngeal cells. Infect Immun (2001) 1.46
Cytotoxic mAb from rheumatic carditis recognizes heart valves and laminin. J Clin Invest (2000) 1.46
A 21-kDa surface protein of Mycobacterium leprae binds peripheral nerve laminin-2 and mediates Schwann cell invasion. Proc Natl Acad Sci U S A (1999) 1.44
A highly conserved region present in transcripts encoding heterologous M proteins of group A streptococci. Infect Immun (1987) 1.40
Passive acquired mucosal immunity to group A streptococci by secretory immunoglobulin A. J Exp Med (1988) 1.39
Biological and immunochemical identity of M protein on group G streptococci with M protein on group A streptococci. Infect Immun (1987) 1.39
Amino acid sequence and physicochemical similarities between streptococcal M protein and mammalian tropomyosin. Proc Natl Acad Sci U S A (1979) 1.38
A study of anti-group A streptococcal monoclonal antibodies cross-reactive with myosin. J Immunol (1986) 1.37
Rational design of live-attenuated recombinant vaccine virus for human respiratory syncytial virus by reverse genetics. Adv Virus Res (1999) 1.34
Antigenic domains of the streptococcal Pep M5 protein. Localization of epitopes crossreactive with type 6 M protein and identification of a hypervariable region of the M molecule. J Exp Med (1986) 1.34
Chemical mutagenesis of dengue virus type 4 yields mutant viruses which are temperature sensitive in vero cells or human liver cells and attenuated in mice. J Virol (2001) 1.33
Therapeutic effects of bacteriophage Cpl-1 lysin against Streptococcus pneumoniae endocarditis in rats. Antimicrob Agents Chemother (2005) 1.33
Primary structure of streptococcal Pep M5 protein: Absence of extensive sequence repeats. Proc Natl Acad Sci U S A (1983) 1.33
Acquisition of the ts phenotype by a chemically mutagenized cold-passaged human respiratory syncytial virus vaccine candidate results from the acquisition of a single mutation in the polymerase (L) gene. Virus Genes (1996) 1.32
Delivery and expression of a heterologous antigen on the surface of streptococci. Infect Immun (1992) 1.32
The occurrence of a protein in the extracellular products of streptococci isolated from patients with acute glomerulonephritis. J Exp Med (1979) 1.31
Identification and characterization of a novel fibronectin-binding protein on the surface of group A streptococci. Infect Immun (1999) 1.31
Cellular reactivity studies to streptococcal antigens. Migration inhibition studies in patients with streptococcal infections and rheumatic fever. J Clin Invest (1974) 1.31
Pathogenic mechanisms in rheumatic carditis: focus on valvular endothelium. J Infect Dis (2000) 1.31
Streptococcal M protein extracted by nonionic detergent. III. Correlation between immunological cross-reactions and structural similarities with implications for antiphagocytosis. J Exp Med (1978) 1.27
Tropomyosin shares immunologic epitopes with group A streptococcal M proteins. J Immunol (1989) 1.26
Antibodies to streptococcal surface enolase react with human alpha-enolase: implications in poststreptococcal sequelae. J Infect Dis (2000) 1.25
Study of heart-reactive antibody in antisera and hybridoma culture fluids against group A streptococci. Infect Immun (1983) 1.25
Streptococcal M protein size mutants occur at high frequency within a single strain. J Exp Med (1986) 1.25
Polyspecificity of antistreptococcal murine monoclonal antibodies and their implications in autoimmunity. J Exp Med (1986) 1.22
Aquaplast for nasal splinting. Ann Plast Surg (1984) 1.19
Role of heavy chain constant domains in antibody-antigen interaction. Apparent specificity differences among streptococcal IgG antibodies expressing identical variable domains. J Immunol (1993) 1.18
Murine monoclonal antibodies reactive with human heart and group A streptococcal membrane antigens. Infect Immun (1984) 1.18
Role of fibrinogen in complement inhibition by streptococcal M protein. Infect Immun (1992) 1.17
Streptococcal M protein peptide with similarity to myosin induces CD4+ T cell-dependent myocarditis in MRL/++ mice and induces partial tolerance against coxsakieviral myocarditis. J Immunol (1996) 1.17
Cloning and sequence analysis of a gene encoding a 67-kilodalton myosin-cross-reactive antigen of Streptococcus pyogenes reveals its similarity with class II major histocompatibility antigens. Infect Immun (1994) 1.17